Exploring the potential of Lactocaseibacillus rhamnosus PMC203 in inducing autophagy to reduce the burden of Mycobacterium tuberculosis
- PMID: 38977511
- PMCID: PMC11231020
- DOI: 10.1007/s00430-024-00794-z
Exploring the potential of Lactocaseibacillus rhamnosus PMC203 in inducing autophagy to reduce the burden of Mycobacterium tuberculosis
Abstract
Mycobacterium tuberculosis, a lethal pathogen in human history, causes millions of deaths annually, which demands the development of new concepts of drugs. Considering this fact, earlier research has explored the anti-tuberculosis potential of a probiotic strain, Lactocaseibacillus rhamnosus PMC203, leading to a subsequent focus on the molecular mechanism involved in its effect, particularly on autophagy. In this current study, immunoblotting-based assay exhibited a remarkable expression of autophagy marker LC3-II in the PMC203 treated group compared to an untreated group. A remarkable degradation of p62 was also noticed within treated cells compared to control. Furthermore, the immunofluorescence-based assay showed significant fold change in fluorescence intensity for alexa-647-LC3 and alexa-488-LC3, whereas p62 was degraded noticeably. Moreover, lysosomal biogenesis generation was elevated significantly in terms of LAMP1 and acidic vesicular organelles. As a result, PMC203-induced autophagy played a vital role in reducing M. tuberculosis burden within the macrophages in treated groups compared to untreated group. A colony -forming unit assay also revealed a significant reduction in M. tuberculosis in the treated cells over time. Additionally, the candidate strain significantly upregulated the expression of autophagy induction and lysosomal biogenesis genes. Together, these results could enrich our current knowledge of probiotics-mediated autophagy in tuberculosis and suggest its implications for innovatively managing tuberculosis.
Keywords: Lactocaseibacillus rhamnosus PMC203; Mycobacterium tuberculosis; Anti-tuberculosis; Autophagy; Probiotics.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures







Similar articles
-
In vitro anti-tuberculosis effect of probiotic Lacticaseibacillus rhamnosus PMC203 isolated from vaginal microbiota.Sci Rep. 2022 May 18;12(1):8290. doi: 10.1038/s41598-022-12413-z. Sci Rep. 2022. PMID: 35585245 Free PMC article.
-
Treatment of Mycobacterium tuberculosis infected macrophages with Rifabutin loaded β-glucan microparticles induces macroautophagy mediated bacillary killing.Int J Biol Macromol. 2024 Dec;283(Pt 2):137256. doi: 10.1016/j.ijbiomac.2024.137256. Epub 2024 Nov 9. Int J Biol Macromol. 2024. PMID: 39528171
-
Lactic acid bacteria enhance autophagic ability of mononuclear phagocytes by increasing Th1 autophagy-promoting cytokine (IFN-gamma) and nitric oxide (NO) levels and reducing Th2 autophagy-restraining cytokines (IL-4 and IL-13) in response to Mycobacterium tuberculosis antigen.Int Immunopharmacol. 2010 Jun;10(6):694-706. doi: 10.1016/j.intimp.2010.03.014. Epub 2010 Apr 7. Int Immunopharmacol. 2010. PMID: 20381647
-
Tuberculosis and the art of macrophage manipulation.Pathog Dis. 2018 Jun 1;76(4):fty037. doi: 10.1093/femspd/fty037. Pathog Dis. 2018. PMID: 29762680 Free PMC article. Review.
-
Cell death at the cross roads of host-pathogen interaction in Mycobacterium tuberculosis infection.Tuberculosis (Edinb). 2018 Dec;113:99-121. doi: 10.1016/j.tube.2018.09.007. Epub 2018 Sep 29. Tuberculosis (Edinb). 2018. PMID: 30514519 Review.
Cited by
-
Deciphering tuberculosis: lysosome-centric insights into pathogenesis and therapies.Front Cell Infect Microbiol. 2025 May 14;15:1582037. doi: 10.3389/fcimb.2025.1582037. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40438237 Free PMC article. Review.
-
Isolation of New Strains of Lactic Acid Bacteria from the Vaginal Microbiome of Postmenopausal Women and their Probiotic Characteristics.Curr Microbiol. 2025 Jan 9;82(2):76. doi: 10.1007/s00284-024-04034-8. Curr Microbiol. 2025. PMID: 39789171 Free PMC article.
-
Effect of Lactic Acid Bacteria-Derived Postbiotic Supplementation on Tuberculosis in Wild Boar Populations.Pathogens. 2024 Dec 8;13(12):1078. doi: 10.3390/pathogens13121078. Pathogens. 2024. PMID: 39770338 Free PMC article.
-
Insights into Autophagy in Microbiome Therapeutic Approaches for Drug-Resistant Tuberculosis.Cells. 2025 Apr 3;14(7):540. doi: 10.3390/cells14070540. Cells. 2025. PMID: 40214493 Free PMC article. Review.
-
Gerobiotics: Exploring the Potential and Limitations of Repurposing Probiotics in Addressing Aging Hallmarks and Chronic Diseases.Probiotics Antimicrob Proteins. 2025 Mar 3. doi: 10.1007/s12602-025-10501-w. Online ahead of print. Probiotics Antimicrob Proteins. 2025. PMID: 40029460 Review.
References
-
- Floyd K, Glaziou P, Zumla A, Raviglione M (2018) The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era. Lancet Respir Med 6:299–314. 10.1016/S2213-2600(18)30057-2 - PubMed
-
- WHO, GLOBAL TUBERCULOSIS REPORT 2022. Report No. 978–92–4–006172–9, 68 (2022).
-
- Raviglione M, Marais B, Floyd K, Lönnroth K, Getahun H, Migliori GB, Harries AD, Nunn P, Lienhardt C, Graham S et al (2012) Scaling up interventions to achieve global tuberculosis control: progress and new developments. The Lancet 379:1902–1913. 10.1016/S0140-6736(12)60727-2 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous